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PURPOSE. To determine to which extent inflammatory cytokines affect chemokine secretion by
primary human choroidal melanocytes (HCMs), their capacity to attract monocytes, and
whether HCMs are able to influence the proliferation of activated T cells.
METHODS. Primary cultures of HCMs were established from eyes of 13 donors. Human
choroidal melanocytes were stimulated with IFN-c and TNF-a or with supernatant from
activated T cells (T-cell–conditioned media [TCM]). Gene expression analysis was performed
by using microarrays. Protein levels were quantified with ELISA or cytometric bead array.
Supernatants of HCMs were assessed for the capability to attract monocytes in a transwell
plate. Proliferation of activated T cells was assessed in a direct coculture with HCMs by a [3H]-
thymidine incorporation assay.
RESULTS. Stimulation of HCMs with TCM or IFN-c and TNF-a resulted in increased expression
and secretion of CXCL8, CXCL9, CXCL10, CXCL11, CCL2, CCL5 and intercellular adhesion
molecule 1. Vascular endothelial growth factor and monocyte migration inhibitory factor
were constitutively expressed without changes in response to proinflammatory cytokines.
Supernatants derived from unstimulated cultures of 10 HCM donors induced a high initial
level of monocyte migration, which decreased upon stimulation with either TCM or IFN-c and
TNF-a. The supernatants from three HCM donors initially showed a low level of monocyte
attraction, which increased after exposure to proinflammatory cytokines. Direct coculture of
HCMs with T cells resulted in inhibition of T-cell proliferation.
CONCLUSIONS. These results showed that normal and activated HCMs are immunologically
active by secreting chemokines, and that HCMs are able to attract monocytes in addition to
inhibiting T-cell proliferation.
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Uveal melanocytes are the most abundant cells in thechoroid.1 They contain two different types of melanin
(eumelanin and pheomelanin), where particularly eumelanin
has an antioxidative effect.2 Furthermore, previous studies have
shown that cultured human choroidal melanocytes (HCMs) are
also able to produce matrix metalloproteinases3 and tissue
plasminogen activator.4
A link between HCMs and inflammatory eye diseases such as
uveitis and age-related macular degeneration (AMD) has been
suggested previously (see Hu et al.1), as in vitro stimulation of
HCMs leads to the secretion of IL-6,1 CXCL8, and CCL2.5 In
both diseases an increased level of those cytokines occurs in
the aqueous humor.6,7 Additionally, in ocular tissue from AMD
patients, increased levels of the chemokine CXCL10 have been
found.8 However, the functions of HCMs have only been
partially characterized and are currently poorly understood.
Macrophages and chemokines are central to inflammatory
events in the uvea. Chemokines are a group of chemotactic
cytokines, which are highly redundant and can drive the
migration of monocytes from the bloodstream into the tissue
where these cells then differentiate into macrophages.9
Macrophages are phagocytic cells that can modulate an
inflammatory response and it has been shown that homeostatic
macrophages reside in the choroid of normal human eyes.10,11
In mice, an age-dependent accumulation of macrophages in the
choroid occurs.12,13 Moreover, it has been shown in mice as
well as in humans that with age, the ratio of the anti-
inflammatory M2 macrophages to proinflammatory M1 macro-
phages increases in the eye,14,15 suggesting age-dependent
functional changes of macrophages in the choroid. Also,
increased levels of circulating inflammatory mediators have
been measured in the serum or plasma of aging individuals,16–18
patients with AMD,8,19 uveitis,20,21 and uveal melanoma.22
While macrophages are present in the healthy choroid, they
have also been implicated in the pathogenesis of these eye
diseases.10,14,23–30 In AMD, macrophages accumulate around
drusen and in choroidal neovascular membranes.10,14,24 Chi-
meric mice in which circulating monocytes express green
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fluorescent protein suggest that most of the macrophages
found in choroidal neovascular lesions are derived from the
peripheral circulation.31
Previously, we have shown that stimulation of uveal
melanoma cell lines with activated T cells induces the
production of high levels of the chemokines CCL2, CCL5,
CXCL8, CXCL9, and CXCL10; the supernatant of these cells is
able to attract monocytes.32 It is not known whether immune
stimulation of primary HCM cultures will have a similar effect
on the innate immune system or whether this is specific for
malignant cells.
For human epidermal melanocytes, studies show an
increased secretion of CXCL8, IL6, IL-1b, and TNF-a, and an
increased expression of CCL2, CCL3, and CCL5 when
stimulated with various Toll-like receptor ligands.33,34 There-
fore, these cells might be of importance in the skin innate
immunity and might be active players in inflammatory events.
Although epidermal melanocytes and uveal melanocytes
originate from neural crest cells during embryonic develop-
ment,35,36 they display a number of different features: In
contrast to epidermal melanocytes, uveal melanocytes do not
transfer melanin to neighboring cells36 and do not express the
receptor for the a-melanocyte–stimulating hormone. There-
fore, uveal melanocytes do not respond to this hormone,
which has an effect on proliferation and melanogenesis.37
We hypothesized that HCMs, like uveal melanoma and
epidermal melanocytes, can secrete chemokines and cause
monocyte migration. We found that stimulation of HCM
cultures led to the secretion of various chemokines, which
stimulated monocyte migration. However, in some donors, the
effect was the opposite, suggesting that the development of
local inflammation is donor specific. Further, HCMs were able
to inhibit the proliferation of stimulated T cells, potentially
playing a role in the immune privilege of the eye.
MATERIALS AND METHODS
Ethics Statement
Ethical approval was waived by the local ethics committee
‘‘Den Videnskabsetiske Komite´ Københavns og Frederiksberg
Kommuner.’’ Samples were identified by date of blood
sampling only and analyzed anonymously. Verbal informed
consent of blood sampling was obtained. For the isolation of
HCMs the study was performed on donor eyes: human eyes
were obtained from the Manchester Royal Eye Hospital Eye
Bank after removal of the corneas for transplantation and with
approval from the Manchester University Research Ethics
Committee. Our research adhered to the tenets of the
Declaration of Helsinki. In all cases, there was prior consent
for the eye tissue to be used for research, and guidelines
established in the Human Tissue Act of 2004 (United Kingdom)
were followed.
Isolation of HCMs
Human choroidal melanocytes were isolated from donor eyes
(donors were 15–76 years old, mean 59 years) with an average
postmortem time of 37 hours (25.5–58 hours). The eyes were
stored in sterile saline solution at 48C before their use. Human
choroidal melanocytes were isolated by combining the
isolation methods from Hu et al.38 and Valtink and Engel-
mann.39 In detail, the eye was cut into halves approximately 8
mm behind the limbus. The anterior segment, vitreous fluid,
and neurosensory retina were removed. The posterior segment
was washed in phosphate-buffered saline (PBS) þ 1% penicil-
lin/streptomycin (Pen/Strep; Gibco, Paisley, UK). To release the
retinal pigment epithelial (RPE) cells, the posterior segment
was covered in 0.125% trypsin-ethylenediaminetetraacetic acid
(EDTA) solution (Gibco) and incubated for 1 hour at 378C at 5%
CO2. The RPE cells were flushed off with PBSþ 1% Pen/Strep.
With forceps, the choroid was carefully removed from the
sclera and placed into a tissue culture dish (60 3 15 mm; BD
Biosciences, Franklin Lakes, NJ, USA). The choroid was kept
whole and HCMs were released by incubation in a mix of 0.5
mg/mL collagenase 1A and 0.5 mg/mL collagenase IV (both
from Sigma-Aldrich Corp., St. Louis, MO, USA) for 1 hour at
378C at 5% CO2 without any agitation. The enzymatic reaction
was stopped by adding a protease inhibitor cocktail in
accordance with the manufacturer’s instructions (Complete
Protease Inhibitor Cocktail; Roche Diagnostics, Mannheim,
Germany). The choroid was washed once with PBSþ 1% Pen/
Strep. The cells were collected and spun at 100g for 5 minutes.
The cells were plated in a T25 flask (Techno Plastic Products
AG, Trasadingen, Switzerland) in FIC medium, which is F12
medium (Gibco) supplemented with 10% fetal calf serum (FCS;
Seralab, West Sussex, UK), 2 mM glutamine (Gibco), 20 ng/mL
basic fibroblast growth factor (Gibco), 0.1 mM isobutylme-
thylxanthine (Sigma-Aldrich Corp.) 10 ng/mL cholera toxin
(Sigma-Aldrich Corp.), and 50 lg/mL gentamicin (Gibco). To
release all HCMs, the choroid was further digested with 0.6 U/
mL dispase II (Gibco) for 18 hours at 378C at 5% CO2 without
any agitation. No morphologic difference was observed by the
isolations using different enzymes. The exact number of cells
was not determined but visually there was a similar degree of
cell density within each flask. Addition of the protease
inhibitor cocktail stopped the proteolysis. The choroid was
thoroughly shaken and passed through a 70-lm cell strainer
(BD Biosciences). Cells were collected, spun down as
described above, and plated in FIC medium in a new T25
flask. The culture medium was supplemented for 3 to 7 days
with 0.1 mg/mL geneticin (Sigma-Aldrich Corp.) to remove any
contaminating fibroblasts and RPE cells, which are more
sensitive to the effects of geneticin than HCMs.38 This
treatment led to pure HCM cultures. Cell culture medium
was changed two to three times a week. Human choroidal
melanocytes were subcultured with 0.05% trypsin/EDTA.
Flow Cytometry
The purity of HCMs from each donor was checked with flow
cytometry. Human choroidal melanocytes express S-100 but no
cytokeratins, whereas RPE cells express both. Fibroblasts
express none of these.38 In brief, cells were harvested, fixed,
and permeabilized with the Cytofix/Cytoperm Kit (BD
Biosciences). The cells were incubated for 30 minutes at 48C
with an Alexa Fluor 488–conjugated antibody to the cytoker-
atin peptides 4, 5, 6, 8, 10, 13, and 18 (pan cytokeratin) (clone
C11; Exbio, Vestec u Prahy, Czech Republic), the correspond-
ing isotype control (Invitrogen, Carlsbad, CA, USA), and the
primary antibody S-100 (clone B32.1; Santa Cruz, Dallas, TX,
USA). After washing, the cells labeled with the primary
antibody S-100 were incubated for 30 minutes at 48C with a
FITC-conjugated F(ab’)2 specific secondary antibody (Sigma-
Aldrich Corp.) that was diluted 1:100. Cells were analyzed on a
LSR II flow cytometer (BD Biosciences). Data were analyzed
with FlowJo version 7.6.5 for Windows (Tree Star, Ashland, OR,
USA).
Preparation of T-Cell–Conditioned Media (TCM)
T cells were purified from fresh whole blood from five healthy
young volunteers, as previously described.40 The healthy status
of the volunteers was self-reported well-being, thereby
excluding any known acute or chronic infections. The purity
of T cells was checked with an FITC-labeled CD3 antibody
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(Dako, Glostrup, Denmark) and found to be above 94% (data
not shown). In total, 33 106 T cells were plated into six-well
plates (Becton Dickinson, Le Pont De Claix, France) in 3 mL X-
VIVO 15 serum-free medium (Lonza BioWhittaker, Verviers,
Belgium) supplemented with 2 mM glutamine and 50 lg/mL
gentamicin (both from Gibco). T cells were activated by using
Dynabeads CD3/CD28 T-Cell Expander (Invitrogen, Oslo,
Norway) for 64 hours at 378C and 5% CO2. The TCM from
each individual donor was spun down, aliquoted separately,
and immediately frozen at 808C.
Stimulation of HCMs
For the experiments, HCMs from 13 donors (Table) were used
at an early passage, which did not exceed pþ4. A total of
100,000 cells were plated into six-well plates and grown for 14
to 21 days in FIC medium. The culture medium was then
changed to the serum-free Melanocyte Growth Medium M2
(PromoCell, Heidelberg, Germany) and the cells cultured for
another 12 to 25 days, at which time they became highly
pigmented and developed a three-dimensional structure. Cell
culture medium was changed two to three times a week. The
cells were stimulated for 48 hours at 378C and 5% CO2 with 1.5
mL TCM and 1.5 mL fresh M2 medium, or 27 ng/mL IFN-c and
10 ng/mL recombinant TNF-a (both from R&D Systems,
Minneapolis, MN, USA) in a total volume of 3 mL. The
concentration of these two cytokines was chosen from the
highest concentration in the TCM of the different T-cell donors.
These two cytokines were chosen in order to determine to
which extent the differential regulation of the genes induced
by activated T cells could be attributed to these cytokines.
After stimulation, supernatant was collected and immediately
frozen at808C for downstream applications. RNAwas purified
from the HCMs by using the NucleoSpin RNA II Kit (Macherey-
Nagel, Du¨ren, Germany) in accordance with the manufactur-
er’s instructions.
Microarrays
RNA was labeled and hybridized to a genome-wide microarray
Human Gene 2.0 ST (Affymetrix, Santa Clara, CA, USA) at the
Copenhagen University Hospital Microarray Center according
to Affymetrix protocols. The microarray data were used as
screening tool and performed for eight HCM donors. Upregu-
lated genes were functionally annotated with Gene Ontology
terms using DAVID Bioinformatics Resources 6.7 (david.abcc.
ncifcrf.gov; provided in the public domain by the National
Institute of Allergy and Infectious Diseases, National Institutes
of Health, Bethesda, MD, USA).41 All microarray data are
Minimum Information About a Microarray Experiment (MI-
AME) compliant, and raw data have been submitted to the
Gene Expression Omnibus (GEO, accession number
GSE70762).
Multiplex Protein Determination
Protein concentration of CXCL8, CXCL9, CXCL10, CXCL11,
CCL2, CCL5, vascular endothelial growth factor (VEGF), and
intercellular adhesion molecule (ICAM)-1 was quantified by
using the BD Cytometric Bead Array (CBA; BD Biosciences)
according to the manufacturer’s instructions. Briefly, we first
performed a preliminary experiment to determine the optimal
dilutions for each sample type. Supernatants from untreated
HCMs were assayed at 1X, 4X, and 20X dilutions, stimulated
HCM supernatants at 5X, 30X, 75X, 150X, and 300X dilutions,
and TCM at 1X and 4X dilutions. For each protein, the dilution
that yielded a concentration within the standard curve was
used. The data were analyzed by using CBA software supplied
by BD Biosciences. The assay was performed in singles for all
13 donors.
Monocyte Purification and Migration Assay
Monocytes were purified from peripheral blood mononuclear
cells from healthy young volunteers by CD14þ selection by
using magnetic activated cell sorting (Miltenyi Biotec, Bergisch
Gladbach, Germany). Monocyte purity was checked with an
FITC-labeled CD14 antibody (BioLegend, San Diego, CA, USA)
and found to be above 98% (data not shown). For the transwell
migration assay, 50,000 cells were placed in a 5.0-lm pore
polycarbonate transwell insert (Nalgene Nunc, Naperville, IL,
USA). For studies with the neutralizing antibody, supernatants
TABLE. Analysis of Monocyte Migration Toward Supernatants From HCM Cultures, Which Were Either Unstimulated or Stimulated With IFN-c and
TNF-a, With and Without Addition of Anti–IFN-c Antibodies
No. CM Sex Age, y
Postmortem
Time, h
Cause of
Death
% Migration
Unstimulated
% Migration
IFN-c þ TNF-a
% Migration
IFN-c þ TNF-a
þ Anti-IFN-c
Fold-Change Value
IFN-c þ TNF-a/
Unstimulated
001 M 56 33 SAH 4.0 19.6 61.7 5
003 F 59 30 ICH 32.2 6.3 18.5 0.2
006 F 56 28.5 ICH 29.4 3.8 11.9 0.1
007 M 51 33.5 PMP 13.6 1.6 10.0 0.1
009 F 76 49 Cancer 25.3 6.7 14.4 0.3
011 F 53 37 Lung cancer 11.1 1.6 5.8 0.1
013 M 47 25.5 Cancer 20.6 12.5 31.0 0.6
014 F 53 44.5 PMP 8.7 16.2 31.0 1.9
015 M 64 29 Pneumonia 18.3 3.3 6.0 0.2
016 F 59 46.5 PMP 8.0 12.9 30.0 1.6
017 F 15 34.5 Cancer 14.5 3.4 13.1 0.2
019 M 37 37 Cardiac arrest 10.8 9.4 24.6 0.9
020 F 73 58 Unknown 25.9 5.9 15.0 0.2
Male (M) and female (F); age; postmortem time in hours; cause of death (SAH, ICH, PMP); percentage of migrated monocytes toward supernatant
from unstimulated HCMs; percentage of migrated monocytes toward supernatant from HCMs stimulated with 27 ng/mL IFN-c and 10 ng/mL TNF-a;
percentage of migrated monocytes toward supernatant from HCMs stimulated with 27 ng/mL IFN-c and 10 ng/mL TNF-a where IFN-c was
neutralized; fold-change of migrated monocytes from IFN-c– and TNF-a–stimulated HCMs/unstimulated HCMs. Based on the fold-changes the HCMs
were pooled into two groups: group 1 with a fold-change of >1 (bold) and group 2 with a fold-change of 1 (italic). In the following graphs the
HCM donors were pooled into those two groups. ICH, intracranial hemorrhage; PMP, pseudomyxoma peritonei; SAH, subarachnoid hemorrhage.
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were preincubated for 3.5 hours at room temperature with 2.4
lg/mL mouse IgG2a anti-human IFN-c antibodies (R&D System,
Minneapolis, MN, USA) before adding to the lower chamber.
The plates were incubated for 2.5 hours at 378C. The filters
were removed and the migrated monocytes were detached by
using PBS containing 20 mM EDTA and 2% bovine serum
albumin (Sigma-Aldrich Corp.). The number of migrated cells
was counted on an LSR II flow cytometer and analyzed with
FlowJo version 7.6.5 for Windows. For the positive control, we
used 100% FCS. To assess the effect of IFN-c and TNF-a on cell
migration, we added 27 ng/mL recombinant IFN-c and 10 ng/
mL recombinant TNF-a to the culture medium with 10% FCS.
The assay was performed in duplicate on two to four
independent monocyte donors.
Monocyte Migration Inhibitory Factor (MIF) ELISA
Migration inhibitory factor was quantified in the HCM
supernatant by sandwich ELISA. The standard curve was
generated from recombinant MIF (BioLegend). A Maxisorp
ELISA plate (Nunc, Rochester, NY, USA) was coated with an
MIF capture antibody at a concentration of 2 lg/mL and
incubated overnight at 48C. The plate was washed and blocked
for 1 hour at room temperature (RT) with PBS containing 10%
FCS. Standards and samples were added in triplicate and
duplicate, respectively, and incubated overnight at 48C. After
washing, the wells were incubated for 1 hour at RT with the
MIF biotinylated detection antibody (BioLegend) at a concen-
tration of 0.5 lg/mL. The plate was washed and incubated for
30 minutes at RT with horseradish peroxidase (HRP)-conjugat-
ed streptavidin (BD Biosciences) diluted 1:1000, followed by
addition of the o-Phenylenediamine dihydrochloride (OPD)
substrate (Dako, Roskilde, Denmark), according to the
manufacturer’s recommendation. The reaction was stopped
with 0.5 M H2SO2 and absorbance was measured at 490 nm on
a microplate reader (Discovery HT-R; BioTek Instruments, Inc.,
Winooski, VT, USA).
Proliferation of T Cells in Coculture With HCMs
A total of 3800 cells were plated into 96-well flat bottom plates
(VWR, Leuven, Belgium) and grown in FIC medium for 16 to
17 days followed by the serum-free medium M2 for 5 to 12
days. For the experiment, the medium was changed to 50% M2
medium and 50% X-VIVO 15 supplemented with 2 mM
glutamine and 50 lg/mL gentamicin. A total of 100,000 frozen
T cells from freshly drawn blood were added directly to the
HCMs, which corresponds to a ratio of HCMs to T cells of 1:1.
For this experiment HCMs from donor 001, 013, 015, and 020
were used. For the T-cell titration experiments with HCM
donor 015, 13105, 23105, and 43 105 frozen purified T cells
from buffy coat were used, which corresponds to a ratio of
HCMs to T cells of 1:1, 1:2, and 1:4. T cells were activated by
using Dynabeads CD3/CD28 T-Cell Expander. After coculture
for 48 hours at 378C with 5% CO2, [3H]-thymidine (0.025 lCi/
lL; Perkin Elmer, Boston, MA, USA) was added to the T cells
and incubated for 18 hours. Cells were harvested on a UniFilter
(Perkin Elmer, Shelton, CT, USA) and [3H]-thymidine incorpo-
ration was measured with a TopCount scintillation counter
(PerkinElmer, Waltham, MA, USA). The experiments were
performed in duplicate or triplicate.
Statistics
Statistical analysis was performed by using the graphic and
statistical software (GraphPad Prism version 4.03; GraphPad
Software, La Jolla, CA, USA), and P values less than 0.05 were
considered significant. The migration assays, the multiplex
protein determination, ELISA, and the T-cell proliferation assay
were analyzed with 1-way ANOVA and Bonferroni’s multiple
comparison test.
RESULTS
Cultures of HCMs
We aimed to obtain HCM cultures with a morphology
comparable to the one observed in the choroid with respect
to pigmentation and sheet-like structure42 (Fig. 1). This
morphology was obtained when we grew the HCMs first in
FIC medium and subsequently in serum-free melanocyte
growth medium M2. It was noticed that in the two oldest
donors (donor 009 and donor 020), aged 79 and 73 years, the
sheet-like structure was only partially achieved. Supplementary
Figure S1 shows the pictures from all donors when grown in
FIC and M2 medium.
All HCM cultures that we used were tested by flow
cytometry analysis for purity, which in all cases was above
97%. Figure 2A shows a representative dot plot, in which
99.5% of HCMs expressed S-100. Expression of the RPE-specific
antigens cytokeratin 8 and 18 was examined by using a pan
cytokeratin antibody against the cytokeratins 4, 5, 6, 8, 10, 13,
and 18, and found to be negative (Fig. 2D).
FIGURE 1. Photomicrographs of cultured HCMs from donor 015 in FIC medium and M2 medium; HCMs became highly pigmented in M2 medium
and developed a three-dimensional structure. Figures are shown at35,310, and320 magnification.
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Upregulation of Chemokine Gene Expression in
HCM Cultures Upon Inflammatory Stimuli
We tested whether soluble factors derived from activated T
cells would influence gene expression of the HCMs and
therefore exposed the cultured HCM cells from donor 001,
003, 007, 014, 015, 016, 019, and 020 to TCM. After exposure
for 48 hours to TCM, gene expression of the eight HCMs was
analyzed with a whole-transcription microarray. By using the
average of the examined HCM donors, a >2-fold criterion, and
an expression level above the median, 642 genes were found to
be upregulated when exposed to TCM. Since IFN-c and TNF-a
are the main inflammatory cytokines derived from activated T
cells, and the HCMs express the corresponding receptors, a
fixed concentration of each was added to the individual HCM
cultures in order to compare to what extend the effect by TCM
can be observed by the use of these cytokines. It was found
that 423 genes were upregulated when exposed to IFN-c and
TNF-a, with a concordance of 388 genes when stimulated with
TCM compared to IFN-c and TNF-a. This indicates that most of
the effect caused by TCM might be due to the presence of IFN-
c and TNF-a in the TCM. The upregulated genes were
functionally annotated by using Gene Ontology terms. This
revealed gene functions related to immune and inflammatory
responses, cell death/apoptosis, proliferation, proteolysis, and
cell adhesion (Fig. 3).
Owing to the close proximity of blood vessels to HCMs,
inflammatory factors present in blood could easily access the
HCMs.43 This might be the case in relation to inflammatory
events such as infections or chronic inflammation. Aging has
been associated with increased levels of proinflammatory
cytokines such as TNF-a in the blood.18 Therefore, we focused
on genes in HCMs encoding for chemokines as well as some
other genes involved in leukocyte migration, such as VEGF and
ICAM-1.
A heat map of genes encoding for chemokines, ICAM-1, and
VEGF-A is presented in Figure 4. VEGF-A was not upregulated
FIGURE 2. Characterization of HCM purity by flow cytometry analysis. Cells were stained with an antibody against S-100, which is expressed on
HCM and RPE cells, and for the cytokeratins 4, 5, 6, 8, 10, 13, and 18 (named pan cytokeratin), which is specific for RPE cells. Fibroblasts express
none of these markers. From a dot plot, cells were gated within live cells (A) followed by single cells (B); 99.5% of the cells were positive for S-100
(C) and negative for pan cytokeratin (D). The black line represents antibody against S-100 or pan cytokeratin. The gray line represents secondary
antibody or isotype control.
FIGURE 3. Microarray gene expression analysis of eight primary HCM
cell cultures from eight donors (001, 003, 007, 014, 015, 016, 019, and
020). Only genes with a fold change of >2 and an expression level
above the mean were included. The upregulated genes were annotated
according to Gene Ontology terms. Shown are the top 25 pathways in
HCM stimulated with TCM or 27 ng/mL IFN-c and 10 ng/mL TNF-a.
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upon inflammatory stimuli but it has a basal expression level.
The eight individual HCM donors showed a high degree of
similarity of upregulated genes when exposed to TCM or IFN-c
and TNF-a. Furthermore, the chemokines CXCL2, CXCL6,
CCL8, and CCL20 were only upregulated when exposed to
TCM, which had a rather low gene expression value. Exposure
of HCMs to TCM or IFN-c and TNF-a, especially induced
CXCL9, CXCL10, CXCL11, CCL2, CCL5, and ICAM-1.
Increased Protein Expression of Chemokines After
Stimulation of HCMs
To examine whether selected genes are also translated into
their corresponding proteins, we used a CBA to quantify the
protein concentration for CXCL8, CXCL9, CXCL10, CXCL11,
CCL2, CCL5, VEGF, and ICAM-1 in culture supernatants.
Pooling the data from 13 donors (Fig. 5), we noticed that
CXCL8, VEGF, ICAM-1, and CCL2 (slightly) were constitutively
expressed, whereas the secretion of all the measured proteins
was induced when stimulating HCMs with IFN-c and TNF-a or
TCM, with an exception for VEGF, which was slightly
downregulated. The concentrations of CXCL9, CXCL10,
CXCL11, and CCL5 were significantly lower when HCMs were
stimulated with TCM compared to stimulation with IFN-c and
TNF-a. T-cell–conditioned media secreted CCL5, ICAM-1, and
some CXCL9. The protein data for all individual samples can be
found in Supplementary Figure S2.
Donor-Dependent Effect on Monocyte Migration
Since exposure of HCMs to TCM or IFN-c and TNF-a induced
expression of CXCL8, CXCL9, CXCL10, CXCL11, CCL2, CCL5,
VEGF, and ICAM-1 in these cells, we wondered whether the
production of these cytokines would influence local inflam-
mation, for example, influx of monocytes. We tested the
different supernatants’ ability to attract monocytes in a
transwell migration assay. We first determined the effect of
the supernatant from unstimulated HCM cultures, then after
stimulation with IFN-c and TNF-a, and finally after exposure to
TCM. From their influence on monocyte migration, we
identified two groups of HCMs: group 1 had a >1 fold-change
(bold) in monocyte migration toward supernatants between
stimulated HCMs and unstimulated HCMs, while group 2 had a
fold-change of 1 (italic), as shown in the Table.
Group 1 comprised three cultures (donor 001, 014, and
016) and had a low basal capacity to attract monocytes.
However, stimulation with IFN-c and TNF-a (Fig. 6A) or TCM
(Fig. 6B) increased monocyte migration.
Group 2 comprised 10 cultures (donor 003, 006, 007, 009,
011, 013, 015, 017, 019, 020), which attracted significantly
more monocytes under unstimulated conditions, compared to
group 1 (Fig. 6A). Supernatants from stimulated HCMs from
group 2 attracted significantly fewer monocytes than superna-
tants from unstimulated HCMs (Figs. 6A, 6B).
Supplementary Figure S3 shows the migration of monocytes
toward supernatants from all the individual HCM donors when
stimulated with IFN-c and TNF-a or TCM.
On the basis of previous experiments where we and others
have shown that IFN-c has an inhibitory effect on monocyte
migration,32,44 we neutralized this cytokine in the supernatants
from HCMs exposed to IFN-c and TNF-a before use in the
migration assay. This led to a significant increase in monocyte
migration in both HCM donor groups (Fig. 6A).
In a previous study32 we have shown that supernatants
from uveal melanoma cell lines cocultured with activated T
cells are able to attract more monocytes than supernatants
from unstimulated cells. In the current study we stimulated the
HCMs with recombinant IFN-c and TNF-a. However, toFI
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compare the results with the uveal melanoma, we cultured the
melanoma cell lines Mel 270 and Mel 290 for the experiments
by using identical conditions as for the HCMs. These
supernatants also showed an increased attraction of mono-
cytes, compared to unstimulated cultures (data not shown).
Therefore, the capability to attract monocytes is not media
dependent or stimulation dependent.
Donor-Specific Effect of HCMs on Monocyte
Migration Does Not Correlate to Chemokine
Secretion or to MIF Levels
We could not establish any relationship between the different
migratory behavior of group 1 and group 2 and the donors’
age, sex, cause of death, and postmortem times. Further, we
examined whether the different migration pattern of the two
groups could be explained by their chemokine expression or
secretion. When we compared the chemokine gene expression
between the two groups, we did not see a difference as shown
in Figure 4: the first three HCM donors are from group 1 and
the other five donors are from group 2.
Next, we measured the chemokine secretion, but this did
not fully explain the difference seen in the migration assay
either, except for CCL2, which was significantly higher in
supernatants from HCMs stimulated with IFN-c and TNF-a in
group 2, and for CCL5, which was significantly lower in group
2 (Supplementary Fig. S4).
Since we could not explain the difference in monocyte
migration of the two groups by their chemokine expression
and secretion, we analyzed whether any difference in the levels
of MIF could be observed in the supernatants between the
groups. Migration inhibitory factor has been reported to inhibit
random migration of monocytes as well as the migration
toward a chemotactic gradient.45 However, different from what
would be expected, the MIF secretion was significantly
decreased from HCM cultures from group 2–TCM-stimulated
cultures compared to group 1–TCM-stimulated HCM cultures.
There was no significant difference between unstimulated and
stimulated HCMs (Fig. 7).
Human Choroidal Melanocytes Inhibit the
Proliferation of Activated T Cells
We further tested whether the eye-derived melanocytes could
modify T-cell responses and we therefore determined whether
they were able to suppress the proliferation of activated T
cells. Human choroidal melanocyte cultures from donor 001
(group 1) and donor 013, 015, and 020 (group 2) were all able
to almost completely inhibit the proliferation of activated T
cells in a direct manner in a ratio of 1:1. Furthermore,
titrations with different numbers of T cells to HCMs from
donor 015 in ratio 1:1, 2:1, and 4:1 (which corresponded to 1
3 105, 2 3 105, and 4 3 105 T cells) showed that the HCMs
were able to inhibit T-cell proliferation at the highest ratio of T
cells to HCMs (Fig. 8).
FIGURE 6. (A) Monocyte migration toward supernatant from unstimulated HCMs and from HCMs stimulated with IFN-c and TNF-a. The 13 HCM
donors were grouped according to their ability to attract monocytes (see Table). Blocking IFN-c resulted in increased monocyte migration in both
groups. (B) The same migration pattern of monocyte toward supernatants from HCMs exposed to TCM then exposed to IFN-c and TNF-a was
observed. Three HCM donors showed an increase in monocyte migration when stimulated with TCM. Ten HCM donors showed a decrease in
monocyte migration toward supernatants from HCMs exposed to TCM compared to unstimulated monocytes. Each dot represents one HCM donor
for one monocyte donor: group 1 (001, 014, and 016); group 2 (003, 006, 007, 009, 011, 013, 015, 017, 019, 020). The results are shown as
percentage of migration where 100% FCS was set to 100%. *P < 0.05; ***P < 0.001.
FIGURE 7. Determination of monocyte MIF in supernatants from
unstimulated HCM cultures (squares), stimulated with TCM (trian-
gles), or stimulated with IFN-c and TNF-a (circles). The HCM donors
were grouped according to the migration assay. Group 1 contains
donors 001, 014, and 016; and group 2 contains donors 003, 006, 007,
009, 011, 013, 015, 017, 019, 020. Migration inhibitory factor was
constitutively expressed and did not show any significant change when
HCMs were stimulated. *P < 0.05.
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DISCUSSION
The uveal melanocytes constitute the major part of the cells in
the choroid. Besides containing melanin, which acts as an
antioxidant, their function is not well characterized.2 As
studies in uveal melanoma have shown that those melano-
cyte-derived malignant cells are able to influence monocyte
migration,32 we investigated whether this was part of their
malignant behavior, or already a characteristic of normal
melanocytes. The purpose of this study was therefore to
investigate whether TCM or IFN-c and TNF-a influenced the
secretion of chemokines by HCMs and their effect on
monocyte migration. Stimulating the HCMs with TCM or IFN-
c and TNF-a should simulate the effect of proinflammatory
factors derived from T cells. Since the HCMs are located in an
area of the body that has the highest blood flow per gram of
tissue of any other organ, they have easy access to these blood-
borne factors.46
In the present study we established primary HCM cultures
from 13 individual donors and managed to obtain HCM
cultures that lasted over 3 weeks and resembled the normal
melanocyte arrangement in the choroid with respect to
pigmentation and sheet-like structures42 (Fig. 1). Our method-
ology differed from most studies where the HCMs used for
experiments have been cultured only for a few days.1,3–5
However, in the study from Lai et al.,47 HCMs are cultured,
similarly to ours, for up to 4 weeks before their use in
experiments.
Microarray analysis of 8 of the 13 donors showed that the
HCMs differentially upregulated 642 genes when exposed to
TCM and 423 genes when exposed to IFN-c and TNF-a.
We found an increased expression and production of the
chemokines CXCL8, CXCL9, CXCL10, CXCL11, CCL2, CCL5,
and the adhesion molecule ICAM-1 (Figs. 4, 5) in response to
simulation of HCMs with TCM or IFN-c and TNF-a. CXCL8,
CCL2, ICAM-1, and VEGF were found to be constitutively
expressed and VEGF did not change in response to proin-
flammatory cytokines (Fig. 5). Part of this finding is supported
by Hu et al.5 who have demonstrated that supernatants from
HCMs display a low basal secretion of CXCL8 and CCL2. To our
knowledge, our study is the first to demonstrate that cultured
HCMs respond to TCM as well as to the inflammatory
cytokines IFN-c and TNF-a by the secretion of multiple
proteins involved in leukocyte attraction.
Murine studies have shown that aging is associated with an
increased expression of the transcripts of chemokines such as
CXCL9, CXCL16, CCL3, CCL5, CCL8, CCL2, and the adhesion
molecule ICAM-1 in the RPE/choroid.48 Our data did not show
any correlation between age of donor (15–76 years, mean 59
years) and the secretion of chemokines (data not shown).
So far, only a few studies have addressed the HCMs’
response to inflammation. Hu et al.5 have shown that the
secretion of IL-6 is induced when HCMs are stimulated with IL-
1b,1 and the secretion of CCL2 and CXCL8 is induced upon
stimulation with lipid polysaccharide.
From in vitro studies, it is known that RPE cells can be a
source of chemokines in the eye: human RPE cells constitu-
tively secrete CCL2 and CXCL8,49–52 both of which are
upregulated in response to oxidative or inflammatory stress
in addition to other chemokines.49–51,53,54 Our study showed
that HCMs can also contribute to the pool of chemokines in the
posterior part of the eye. Of note, stimulation of polarized RPE
cells led to very low basolateral secretion of CXCL9, CXCL10,
and CXCL11,51 suggesting that HCMs must be the major source
of these chemokines outside the outer blood–retinal barrier.
When we compared the HCMs with uveal melanoma cell
lines, we found the same genes upregulated, namely CXCL8,
CXCL9, CXCL10, CXCL11, CCL2, CCL5, and ICAM-1 in
response to proinflammatory cytokines. This was confirmed
on the protein level.32 We demonstrated that malignant
transformed uveal melanomas still display a similarity to HCMs
in terms of gene expression and protein secretion as shown in
Supplementary Table S1, comparing the gene expression
profile of unstimulated and stimulated melanoma cell lines
with primary HCM cultures.
Besides chemokines, macrophages are important players in
the inflammatory reaction in the uvea. Resident macrophages
are present in the choroid and appear to be of importance in
providing homeostatic functions such as immunosurveillance
and prevention of retinal/choroidal inflammation by removal of
waste material.10,13,55 With age, increased numbers of leuko-
cytes, and in particular macrophages, are found in the choroid
and associated with Bruch’s membrane,12,13,48 with a higher
proportion of the anti-inflammatory M2 macrophages com-
pared to proinflammatory M1 macrophages.14,15
Therefore, we investigated whether supernatants from the
HCMs were able to attract monocytes. Analysis of supernatants
from unstimulated HCM cultures showed that 10 of 13 donors
showed a high initial level of monocyte migration, which
decreased upon stimulation with IFN-c and TNF-a or TCM. The
other three donors showed the opposite effect, as their
supernatants induced an increased monocyte attraction in
response to IFN-c and TNF-a (Fig. 6A) or TCM (Fig. 6B). The
supernatant of the HCMs from donor 001 showed the highest
monocyte migration when stimulated with IFN-c and TNF-a;
we were able to test the HCMs of the other eye from the same
FIGURE 8. Human choroidal melanocytes inhibit CD3/CD28-induced T-cell proliferation. (A) 13 105 frozen T cells from freshly drawn blood were
cultured alone (black bar) or in direct contact with HCM donor 001, 013, or 020 (white bar). The striped bar illustrates the proliferation of HCMs
only. (B) Different numbers of T cells (13 105–43 105) were cultured alone or in direct contact with HCM donor 015: 100,000 CM cells were even
able to inhibit T-cell proliferation at the highest T-cell number. Results are shown as counts per minute: n¼ 3 for CM donor 001 and 020, and n¼ 2
for CM donors 013 and 015. Error bars are SEM. *P < 0.05 and ***P < 0.001.
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donor as well and observed a comparable monocyte migration
pattern (data not shown). These data suggest that the
migration of monocytes is donor dependent and not eye
dependent. When comparing the two groups on the basis of
measured chemokine concentrations, no obvious difference
was found. CCL2, which is a highly potent chemoattractant for
monocytes, was different from what would be expected,
significantly increased in group 2 compared to group 1 when
stimulated with IFN-c and TNF-a (Supplementary Fig. S4).
Since it has been shown that MIF can inhibit monocyte
migration,45 we examined the protein concentration of MIF in
the supernatants (Fig. 7). However, these results also did not
explain the difference in monocyte migration toward HCM
supernatants between the two groups. Therefore, the mech-
anism behind this needs further elaboration. Neutralization
studies could help to identify the chemokine(s) that is(are)
responsible for the attraction of monocytes in the migration
assay.
Human choroidal melanocytes are also considered as
antigen-presenting cells in experimental melanin-induced
uveitis and in human Vogt-Koyanagi-Harada disease and thus
might be of importance in inflammatory eye conditions.1 We
could show that the HCMs upregulated a number of the major
histocompatibility complex genes when exposed to inflamma-
tory stimuli (data not shown). However, this upregulation
needs to be confirmed on the protein level and further
experiments are necessary to determine whether HCMs can
function as professional antigen-presenting cells.
It is known that uveal melanoma cells and RPE cells are able
to inhibit T-cell proliferation.56–59 In this study we showed that
HCMs from group 1 (donor 001) as well as from group 2
(donor 013, 015, and 020) also had the ability to exert a strong
inhibitory effect on T-cell proliferation in a direct coculture
(Fig. 8). We could not observe any difference between the two
groups in their ability to inhibit T-cell proliferation, as HCMs
from both groups almost completely inhibited T-cell prolifer-
ation. The eye is an immune-privileged organ meaning that
multiple mechanisms protect the eye from inflammatory
insults, which is of importance since the eye is a rather
sensitive organ with poor regenerative capacity.60 Our results
indicate that HCMs on the one hand secrete proinflammatory
chemokines, but on the other hand are also likely to protect
the choroid from inflammatory insults by inhibiting T-cell
proliferation, and therefore take part in the establishment of
the immune privilege in the posterior part of the eye. To our
knowledge this is the first proof of the ability of nonmalignant
melanocytes to inhibit T-cell proliferation.
In conclusion, the present study showed that HCMs are
immunologically active. They have the capacity to constitu-
tively secrete CXCL8, CCL2, VEGF, and ICAM-1 at a low level.
Exposure of inflammatory stimuli induced the secretion of
CXCL8, CXCL9, CXCL10, CCL2, CCL5, and ICAM-1. Ten of the
HCM donors had a high basal capability to attract monocytes,
which was significantly decreased upon stimulation with TCM
or IFN-c and TNF-a. An opposite pattern was observed in the
remaining three HCM cultures. These data suggest that HCMs
constitutively secrete chemokines into the posterior part of the
eye, may respond to systemically increased levels of proin-
flammatory cytokines, and are capable to attract monocytes.
With this in mind, it is likely that these HCMs contribute to the
immune-pathogenesis of uveal melanoma, AMD, or uveitis.
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